KDLY: Kindly MD Corp Market Cap to Revenue Ratio

Brandmark of Kindly MD Corp (KDLY)

Geopolitical strife is creating challenges for raw material supplies and patents, triggering volatility in the fundamental P/S ratio for Kindly MD, Inc. (KDLY). The value of 2.50 serves as the current reading for this metric. Revenue stability is based on government insurance for pain management procedures. Capitalization growth is supported by the implementation of an AI platform for predictive risk analysis and billing automation, which optimizes the internal processes of the clinic network.

Kindly MD Corp - KDLY Market Cap to Revenue (period 06/01/2024 - 11/15/2026)

Metric breakdowns and analytics for kindlymd.com (KDLY)

- stock price and consensus target price:
General company analysis:Kindly MD Corp (KDLY)
Finished products of Kindly MD, Inc.

The P/S multiple relates the market value of a business to its sales volume, allowing for the determination of an asset's overvaluation relative to its generated cash flow. By analyzing the dynamics of the market cap-to-revenue ratio, an investor can assess the impact of the technological plateau of Kindly MD, Inc. (KDLY), where the implementation of specialized electronic health record (EHR) software becomes a key factor in maintaining the efficiency of the operating model and the company's valuation.

Who Kindly MD, Inc. competes with

HCA (HCA Healthcare) - Market Capitalization-to-Revenue Ratio|Tenet Healthcare Corporation - Market Cap to Revenue|Fresenius Medical (FMS) - Price to Sales|Solventum Corp - P/S Multiple|Price-to-Sales Ratio EHC|Universal Health Services (UHS) - Price-to-Revenue Ratio|DaVita - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue RDNT|OPCH: Market Capitalization-to-Revenue Ratio|Market Cap to Revenue SGRY (Surgery Partners, Inc.)|PINC (Premier, Inc.) - Market Capitalization-to-Revenue Ratio|National Vision - Market Cap to Revenue|Price-to-Revenue Coefficient Progyny Inc (PGNY)|Ardent Health - P/S Multiple|Price-to-Revenue Coefficient Select Medical Corp SEM|ASTH: P/S Multiple|Market Cap to Revenue Ratio MD|USPH (US Physical Therapy Inc) - P/S Multiple|PNTG: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Organogenesis Corp (ORGO)|NUTX (Nutex Health Corp) - Market Capitalization-to-Revenue Ratio|P/S Multiple AUNA (Auna S.A.)|SBC Medical Group Holdings Inc (SBC) - Price to Sales|EOLS - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Market Cap to Revenue|Market Cap to Revenue Ratio MDWD|Price-to-Revenue Ratio biote Corp.|Price to Sales thejoint.com JYNT|P/S Multiple DCGO|Market Cap to Revenue P3 Health PIII|P/S Multiple GANX (Gain Therapeutics Inc.)|P/S Multiple EUDA Health Holdings Limited EUDA|baselmedical.com - P/S Multiple|CLGN: Price-to-Revenue Ratio|Cuprina Holdings (Cayman) Ltd. (CUPR) - Price-to-Revenue Ratio|Market Cap to Revenue Concord Medical|AMS (American Shared Hospital Services Inc) - P/S Multiple|MEDIROM Corp (MRM) - Price-to-Revenue Coefficient|P/S Multiple ALBT|Price-to-Revenue Coefficient DIH Holding|P/S Multiple XAGE (carmellcosmetics.com)|NIVF: Market Cap to Revenue Ratio|ATIP: Market Cap to Revenue|CareMax Medical Group - Market Cap to Sales Volume|ModivCare (MODV) - Price-to-Revenue Ratio|NVOS (novointegrated.com) - Price-to-Revenue Ratio|SSY (SunLink Health Systems Inc.) - P/S Multiple|BACK (IMAC Holdings Inc) - Market Cap to Sales Volume